NFKB1 and Duchenne muscular dystrophy: Interestingly, the only pharmacological intervention for Duchenne Muscular Dystrophy (DMD) is treatment with glucocorticoids, agents that are thought to act by suppressing inflammation via inhibition of NFκB, stabilizing the sarcolemma, reducing necrosis, and increasing muscle mass (70).